Gujarat Terce Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 130.2 million compared to INR 119.05 million a year ago. Revenue was INR 131 million compared to INR 119.69 million a year ago. Net income was INR 6.73 million compared to net loss of INR 0.028 million a year ago. Basic earnings per share from continuing operations was INR 0.91. Diluted earnings per share from continuing operations was INR 0.91.
For the nine months, sales was INR 357.68 million compared to INR 338.94 million a year ago. Revenue was INR 360.07 million compared to INR 341.47 million a year ago. Net loss was INR 3 million compared to INR 24.75 million a year ago. Basic loss per share from continuing operations was INR 0.4 compared to INR 3.34 a year ago. Diluted loss per share from continuing operations was INR 0.4 compared to INR 3.34 a year ago.